nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.0322	0.0322	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0202	0.0202	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—P2RY11—narcolepsy	0.0189	0.0189	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0188	0.0188	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0167	0.0167	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.0156	0.0156	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—HTR2A—narcolepsy	0.012	0.012	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HCRTR1—narcolepsy	0.011	0.011	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HCRTR2—narcolepsy	0.011	0.011	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—P2RY11—narcolepsy	0.0106	0.0106	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.00993	0.00993	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00982	0.00982	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00982	0.00982	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00948	0.00948	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00911	0.00911	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00911	0.00911	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HCRT—narcolepsy	0.00901	0.00901	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.00882	0.00882	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.0088	0.0088	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00849	0.00849	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00849	0.00849	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CHKB—narcolepsy	0.00839	0.00839	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00835	0.00835	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0082	0.0082	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00809	0.00809	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00809	0.00809	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00806	0.00806	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00787	0.00787	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.00782	0.00782	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.00748	0.00748	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00741	0.00741	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00727	0.00727	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00727	0.00727	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00724	0.00724	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00724	0.00724	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00704	0.00704	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00704	0.00704	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00702	0.00702	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00699	0.00699	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—TRH—narcolepsy	0.00683	0.00683	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0068	0.0068	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00669	0.00669	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00665	0.00665	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00626	0.00626	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00626	0.00626	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00611	0.00611	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00603	0.00603	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00603	0.00603	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00594	0.00594	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CPT1B—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.00567	0.00567	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00554	0.00554	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00536	0.00536	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00536	0.00536	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00535	0.00535	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00532	0.00532	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.00531	0.00531	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00518	0.00518	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00463	0.00463	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.0046	0.0046	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00452	0.00452	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0045	0.0045	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00444	0.00444	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00442	0.00442	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0044	0.0044	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00408	0.00408	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00408	0.00408	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00397	0.00397	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00394	0.00394	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00392	0.00392	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00377	0.00377	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00376	0.00376	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00361	0.00361	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00345	0.00345	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00341	0.00341	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00336	0.00336	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00335	0.00335	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00327	0.00327	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00327	0.00327	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00302	0.00302	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00302	0.00302	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CHKB—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00286	0.00286	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00202	0.00202	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CPT1B—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CHKB—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000947	0.000947	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000947	0.000947	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000916	0.000916	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000906	0.000906	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000867	0.000867	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000773	0.000773	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.00077	0.00077	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.00076	0.00076	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000759	0.000759	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000759	0.000759	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CPT1B—narcolepsy	0.000734	0.000734	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000706	0.000706	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000675	0.000675	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CHKB—narcolepsy	0.000665	0.000665	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000641	0.000641	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000627	0.000627	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000598	0.000598	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.00057	0.00057	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.00056	0.00056	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.00056	0.00056	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000457	0.000457	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000452	0.000452	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000379	0.000379	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000337	0.000337	CbGpPWpGaD
